In the News

Line Art 1
Line Art 2
Line Art 3
Line Art 4
As Seen In: MedCity News

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Seen In: Forbes

Drug Price Transparency Stymies Consumers, New Survey Shows

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

As Seen In: Drug Topics

NCPA Annual Convention and Expo: Prescryptive Health

See highlights for the annual NCPA convention in Kansas City, including sessions from Prescryptive Health! Conference Preview: NCPA Annual…

As Seen In: BenefitsPRO

3 reasons why owning your pharmacy benefits data matters

Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…

As Seen In: Pharmacy Times

With Cash Customers on the Rise, AI Could be Key to Pharmacy Pricing Profitability

Paige Clark, RPh, takes an in-depth look at AI’s impact on the pharmacy bottom line. Read more in…

As Seen In: Becker's Payer Issue

How to launch a PBM, Mark Cuban style

“With his name, brand and reputation, it has created a lot of interest and appropriately put a brighter…

As Seen In: Pharmacy Times

Is Your Pharmacy Ready for a Data Hack? Take These 3 Steps

Paige Clark, RPh, writes about the three steps all community pharmacists should take to be ready for security…

As Seen In: Becker's Payer Issue

“They’re now exposed”: What an FTC probe, federal legislation, and state actions could mean for the PBM industry

Hear what our co-founder and CEO, Chris Blackley, has to say about the recent FTC probe into the…

As Seen In: BenefitsPRO

Prescription benefits: 3 things you should be discussing with your PBM consultant

Keep reading in Benefits PRO: Prescription benefits: 3 things you should be discussing with your PBM consultant

As Seen In: MedCity News

Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News

Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News

As Seen In: CIO

10 ways to recession-proof your IT career

With inflation and other global factors increasing the risk of recession, savvy IT pros are reconsidering their approaches…

As Seen In: Pharmacy Times

High-Deductible Health Plans Mean More Cash-Paying Customers for Prescriptions: Here’s How to Find a Cash Solution That Works

High-Deductible Health Plans Mean More Cash-Paying Customers for Prescriptions: Here’s How to Find a Cash Solution That Works…